HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.

Abstract
Metastasis-associated lung adenocarcinoma transcript 1(MALAT1), a long non-coding RNA (lncRNA), is up-regulated in many solid tumors and associated with cancer metastasis and recurrence. However, its role in hepatocellular carcinoma (HCC) remains poorly understood. In the present study, we evaluated the expression of MALAT1 by quantitative real-time PCR in 9 liver cancer cell lines and 112 HCC cases including 60 cases who received liver transplantation (LT) with complete follow-up data. Moreover, small interfering RNA (siRNA) was used to inhibit MALAT1 expression to investigate its biological role in tumor progression. We found that MALAT1 was up-regulated in both cell lines and clinical tissue samples. Patients with high expression level of MALAT1 had a significantly increased risk of tumor recurrence after LT, particularly in patients who exceeded the Milan criteria. On multivariate analysis, MALAT1 was an independent prognostic factor for predicting HCC recurrence (hazard ratio, 3.280, P = 0.003).In addition, inhibition of MALAT1 in HepG2 cells could effectively reduce cell viability, motility, invasiveness, and increase the sensitivity to apoptosis. Our data suggest that lncRNA MALAT1 play an important role in tumor progression and could be a novel biomarker for predicting tumor recurrence after LT and serve as a promising therapeutic target.
AuthorsMing-chun Lai, Zhe Yang, Lin Zhou, Qian-qian Zhu, Hai-yang Xie, Feng Zhang, Li-ming Wu, Lei-ming Chen, Shu-sen Zheng
JournalMedical oncology (Northwood, London, England) (Med Oncol) Vol. 29 Issue 3 Pg. 1810-6 (Sep 2012) ISSN: 1559-131X [Electronic] United States
PMID21678027 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MALAT1 long non-coding RNA, human
  • RNA, Long Noncoding
  • RNA, Small Interfering
Topics
  • Adult
  • Carcinoma, Hepatocellular (genetics, pathology)
  • Female
  • Humans
  • Liver Neoplasms (genetics, pathology)
  • Liver Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Recurrence, Local (genetics, pathology)
  • Prognosis
  • RNA, Long Noncoding (genetics)
  • RNA, Small Interfering
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: